Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111


Depressive mood ratings are reduced by MDMA in female polydrug ecstasy users homozygous for the l-allele of the serotonin transporter.

Kuypers KPC, de la Torre R, Farre M, Xicota L, de Sousa Fernandes Perna EB, Theunissen EL, Ramaekers JG.

Sci Rep. 2018 Jan 18;8(1):1061. doi: 10.1038/s41598-018-19618-1.


Meta-analysis of the interaction between serotonin transporter promoter variant, stress, and posttraumatic stress disorder.

Zhao M, Yang J, Wang W, Ma J, Zhang J, Zhao X, Qiu X, Yang X, Qiao Z, Song X, Wang L, Jiang S, Zhao E, Yang Y.

Sci Rep. 2017 Nov 28;7(1):16532. doi: 10.1038/s41598-017-15168-0.


Population differences in associations of serotonin transporter promoter polymorphism (5HTTLPR) di- and triallelic genotypes with blood pressure and hypertension prevalence.

Williams RB, Bishop GD, Haberstick BC, Smolen A, Brummett BH, Siegler IC, Babyak MA, Zhang X, Tai ES, Lee JJ, Tan M, Teo YY, Cai S, Chan E, Halpern CT, Whitsel EA, Bauldry S, Harris KM.

Am Heart J. 2017 Mar;185:110-122. doi: 10.1016/j.ahj.2016.12.013. Epub 2016 Dec 29.


A pilot study exploring the association of morphological changes with 5-HTTLPR polymorphism in OCD patients.

Honda S, Nakao T, Mitsuyasu H, Okada K, Gotoh L, Tomita M, Sanematsu H, Murayama K, Ikari K, Kuwano M, Yoshiura T, Kawasaki H, Kanba S.

Ann Gen Psychiatry. 2017 Jan 17;16:2. doi: 10.1186/s12991-017-0126-6. eCollection 2017.


The influence of 5-HTTLPR transporter genotype on amygdala-subgenual anterior cingulate cortex connectivity in autism spectrum disorder.

Velasquez F, Wiggins JL, Mattson WI, Martin DM, Lord C, Monk CS.

Dev Cogn Neurosci. 2017 Apr;24:12-20. doi: 10.1016/j.dcn.2016.12.002. Epub 2016 Dec 23.


Personality as an intermediate phenotype for genetic dissection of alcohol use disorder.

Oreland L, Lagravinese G, Toffoletto S, Nilsson KW, Harro J, Robert Cloninger C, Comasco E.

J Neural Transm (Vienna). 2018 Jan;125(1):107-130. doi: 10.1007/s00702-016-1672-9. Epub 2017 Jan 4. Review.


Extending Previous cG×I Findings on 5-HTTLPR's Moderation of Intervention Effects on Adolescent Substance Misuse Initiation.

Schlomer GL, Cleveland HH, Feinberg ME, Wolf PSA, Greenberg MT, Spoth RL, Redmond C, Tricou EP, Vandenbergh DJ.

Child Dev. 2017 Nov;88(6):2001-2012. doi: 10.1111/cdev.12666. Epub 2016 Nov 8.


Associations Between Neurotransmitter Genes and Fatigue and Energy Levels in Women After Breast Cancer Surgery.

Eshragh J, Dhruva A, Paul SM, Cooper BA, Mastick J, Hamolsky D, Levine JD, Miaskowski C, Kober KM.

J Pain Symptom Manage. 2017 Jan;53(1):67-84.e7. doi: 10.1016/j.jpainsymman.2016.08.004. Epub 2016 Oct 5.


Prevention of Early Substance Use Mediates, and Variation at SLC6A4 Moderates, SAAF Intervention Effects on OXTR Methylation.

Beach SRH, Lei MK, Brody GH, Philibert RA.

Prev Sci. 2018 Jan;19(1):90-100. doi: 10.1007/s11121-016-0709-5.


PTSD, alcohol dependence, and conduct problems: Distinct pathways via lability and disinhibition.

Simons JS, Simons RM, O'Brien C, Stoltenberg SF, Keith JA, Hudson JA.

Addict Behav. 2017 Jan;64:185-193. doi: 10.1016/j.addbeh.2016.08.044. Epub 2016 Sep 4.


Does preoperative depression and/or serotonin transporter gene polymorphism predict outcome after laparoscopic cholecystectomy?

Wright B, Alexander D, Aghahoseini A; York Surgical Outcomes Research Team.

BMJ Open. 2016 Sep 6;6(9):e007969. doi: 10.1136/bmjopen-2015-007969.


Brain-Derived Neurotrophic Factor (Val66Met) and Serotonin Transporter (5-HTTLPR) Polymorphisms Modulate Plasticity in Inhibitory Control Performance Over Time but Independent of Inhibitory Control Training.

Enge S, Fleischhauer M, Gärtner A, Reif A, Lesch KP, Kliegel M, Strobel A.

Front Hum Neurosci. 2016 Jul 29;10:370. doi: 10.3389/fnhum.2016.00370. eCollection 2016.


Molecular Signatures of Natural Selection for Polymorphic Genes of the Human Dopaminergic and Serotonergic Systems: A Review.

Taub DR, Page J.

Front Psychol. 2016 Jun 8;7:857. doi: 10.3389/fpsyg.2016.00857. eCollection 2016. Review.


Stressing over anxiety: A novel interaction of 5-HTTPLR genotype and anxiety-related phenotypes in older adults.

Fogelman N, Mikhailik A, Mueller-Alcazar A, Bernard K, Canli T.

Psychoneuroendocrinology. 2016 Sep;71:36-42. doi: 10.1016/j.psyneuen.2016.05.012. Epub 2016 May 12.


Serotonin Transporter and COMT Polymorphisms as Independent Predictors of Health-related Quality of Life in Patients with Panic Disorder.

Kang E, Choe AY, Kim B, Lee JY, Choi TK, Na HR, Lee SH.

J Korean Med Sci. 2016 May;31(5):757-63. doi: 10.3346/jkms.2016.31.5.757. Epub 2016 Mar 28.


Genetic Polymorphism in the Promoter Region of Serotonin Transporter: Implications for Ethanol Abuse in Children and Adolescents.

de Oliveira CE, Oda JM, Ariza CB, Guembarovski RL, Hirata BK, de Almeida FC, André ND, Fungaro MH, Watanabe MA.

J Can Acad Child Adolesc Psychiatry. 2016 Winter;25(1):43-9. Epub 2016 Feb 1.


Maintenance of Chronic Fatigue Syndrome (CFS) in Young CFS Patients Is Associated with the 5-HTTLPR and SNP rs25531 A > G Genotype.

Meyer B, Nguyen CB, Moen A, Fagermoen E, Sulheim D, Nilsen H, Wyller VB, Gjerstad J.

PLoS One. 2015 Oct 16;10(10):e0140883. doi: 10.1371/journal.pone.0140883. eCollection 2015.


Life events, genetic susceptibility, and smoking among adolescents.

Pampel FC, Boardman JD, Daw J, Stallings MC, Smolen A, Haberstick BC, Widaman KF, Neppl TK, Conger RD.

Soc Sci Res. 2015 Nov;54:221-32. doi: 10.1016/j.ssresearch.2015.08.001. Epub 2015 Aug 14.


A review of 5-HT transporter linked promoter region (5-HTTLPR) polymorphism and associations with alcohol use problems and sexual risk behaviors.

Rubens M, Ramamoorthy V, Attonito J, Saxena A, Appunni S, Shehadeh N, Dévieux JG.

J Community Genet. 2016 Jan;7(1):1-10. doi: 10.1007/s12687-015-0253-1. Epub 2015 Sep 4.

Supplemental Content

Support Center